臨牀消化器内科 Vol.26 No.13(3-1)


特集名 肝門部〜肝内胆管癌
題名 肝内胆管癌 -- Topics (1) 胆管細胞癌
発刊年月 2011年 12月
著者 阪本 良弘 東京大学医学部肝胆膵外科/人工臓器・移植外科
著者 山下 俊 東京大学医学部肝胆膵外科/人工臓器・移植外科
著者 青木 琢 東京大学医学部肝胆膵外科/人工臓器・移植外科
著者 長谷川 潔 東京大学医学部肝胆膵外科/人工臓器・移植外科
著者 菅原 寧彦 東京大学医学部肝胆膵外科/人工臓器・移植外科
著者 國土 典宏 東京大学医学部肝胆膵外科/人工臓器・移植外科
【 要旨 】 胆管細胞癌(肝内胆管癌)は肝細胞癌と同様原発性肝癌に分類され,二次分枝以降の胆管に発生し,組織学的には腺癌である.周囲組織への浸潤やリンパ節転移を伴って進行する.末梢型は無症状だが肝門に浸潤すると閉塞性黄疸を伴う.画像上は辺縁八つ頭状の乏血性腫瘍として描出される.肉眼型では腫瘤形成型と腫瘤形成+胆管周囲増殖型が全体の9割を占め,後者のほうが予後不良である.治療は外科切除が主体で,化学療法のエビデンスは乏しい.リンパ節転移の有無,腫瘍数,血清CA19-9値が主要な術後予後因子である.
Theme Hilar and Intrahepatic Cholangiocarcinoma
Title Cholangiocellular Carcinoma
Author Yoshihiro Sakamoto Hepato-Biliary-Pancreatic Surgery Division, Department of Surgery, Graduate School of Medicine, University of Tokyo
Author Suguru Yamashita Hepato-Biliary-Pancreatic Surgery Division, Department of Surgery, Graduate School of Medicine, University of Tokyo
Author Taku Aoki Hepato-Biliary-Pancreatic Surgery Division, Department of Surgery, Graduate School of Medicine, University of Tokyo
Author Kiyoshi Hasegawa Hepato-Biliary-Pancreatic Surgery Division, Department of Surgery, Graduate School of Medicine, University of Tokyo
Author Yasuhiko Sugawara Hepato-Biliary-Pancreatic Surgery Division, Department of Surgery, Graduate School of Medicine, University of Tokyo
Author Norihiro Kokudo Hepato-Biliary-Pancreatic Surgery Division, Department of Surgery, Graduate School of Medicine, University of Tokyo
[ Summary ] Cholangiocellular carcinoma (CCC, i. e., intrahepatic cholangiocarcinoma) is a primary hepatic cancer, similar to hepatocellular carcinoma, arising from the 2nd or higher order branch of the bile duct. Histopathologically, CCC is a form of adenocarcinoma and can involve adjacent structures or exhibit nodal metastasis. Patients with CCC in the peripheral liver are asymptomatic, while patients with CCC involving the hepatic hilum present with obstructive jaundice. CCC exhibits irregular boundaries between surrounding hepatic parenchyma and hypovascular tissue, as observed in diagnostic imaging. Macroscopically, the mass forming type and the mass forming + periductal infiltrating type are dominant (90 % of all cases). The prognosis for patients with the latter type is worse than that with former type. The first treatment should be surgical resection. However, clinical evidence concerning the efficacy of chemotherapy is limited. Important prognostic factors after surgical resection are nodal metastasis, number of tumors and serum CA19 -9 levels.
戻る